• Science & Technology
• Health & Medicine

ASCO 2011 – A year of promise for treating melanoma

8 June 2011

• Science & Technology
• Health & Medicine

ASCO 2011 – the challenge and promise of the genomic era

8 June 2011

• Health & Medicine

Cancer Research UK leads global lung cancer drug trial

Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust. Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust.

29 March 2011

• Health & Medicine
• Science & Technology

Ovarian cancer treatment – a bright future

14 March 2011

• Health & Medicine

Getting medical research up the Parliamentary agenda

2 March 2011

• Health & Medicine

Our CancerHelp UK clinical trials database is ten

17 February 2011

• Science & Technology
• Health & Medicine

2010 - A year of progress

17 December 2010

• Health & Medicine

New podcast: Aspirin advice, progress in children’s cancer, and fear or fate?

15 December 2010

• Health & Medicine

Trial results bring hope to children with leukaemia

4 December 2010

• Health & Medicine

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns. A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.

4 December 2010

• Health & Medicine

Study confirms long-term benefit of anastrozole to stop breast cancer returning

A major international trial has confirmed the long-term benefit of anastrozole to help stop breast cancer coming back or developing in the other breast in postmenopausal women with hormone sensitive early breast cancer, according to a study published in Lancet Oncology today (Wednesday). A major international trial has confirmed the long-term benefit of anastrozole to help stop breast cancer coming back or developing in the other breast in postmenopausal women with hormone sensitive early breast cancer, according to a study published in Lancet Oncology today (Wednesday).

1 December 2010

• Science & Technology
• Health & Medicine

Podcast: cervical cancer screening, prostate cancer treatment, lung surgery rates and a big day out at Westminster

19 November 2010